Showing results (31-40 of 125) with videos related to

Sort By:
Pageof 13
Pediatric Research|June 15, 2024
Acute myeloid leukemia stem cell signature gene EMP1 is not an eligible therapeutic targetLaurens Van Camp, Barbara Depreter, Jilke De Wilde, et al.
Pediatric Blood & Cancer|May 22, 2018
Associations between neutrophil recovery time, infections and relapse in pediatric acute myeloid leukemiaDitte J A Løhmann, Peter H Asdahl, Jonas Abrahamsson, et al.
Pediatric Blood & Cancer|March 9, 2019
Use of granulocyte colony-stimulating factor and risk of relapse in pediatric patients treated for acute myeloid leukemia according to NOPHO-AML 2004 and DB AML-01Ditte J A Løhmann, Peter H Asdahl, Jonas Abrahamsson, et al.
Pediatric Research|October 17, 2020
Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approachBarbara Depreter, Barbara De Moerloose, Karl Vandepoele, et al.
British Journal of Haematology|February 15, 2020
Prospective, real-time monitoring of pegylated Escherichia coli and Erwinia asparaginase therapy in childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma in BelgiumVeerle Mondelaers, Alina Ferster, Anne Uyttebroeck, et al.
The Journal of Molecular Diagnostics : JMD|July 25, 2017
Digital Multiplex Ligation-Dependent Probe Amplification for Detection of Key Copy Number Alterations in T- and B-Cell Lymphoblastic LeukemiaAnne Benard-Slagter, Ilse Zondervan, Karel de Groot, et al.
Blood Advances|January 26, 2021
Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapyJochen Buechner, Stephan A Grupp, Hidefumi Hiramatsu, et al.
Cancer Medicine|September 19, 2019
Associations between pretherapeutic body mass index, outcome, and cytogenetic abnormalities in pediatric acute myeloid leukemiaDitte J A Løhmann, Peter H Asdahl, Jonas Abrahamsson, et al.
Cancers|May 14, 2022
Deciphering the Non-Coding RNA Landscape of Pediatric Acute Myeloid LeukemiaJolien Vanhooren, Laurens Van Camp, Barbara Depreter, et al.
Leukemia|April 15, 2022
Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemiaTheodore W Laetsch, Shannon L Maude, Adriana Balduzzi, et al.
Pageof 13